Skip to Content

WATSON 836 7.5 (Clorazepate 7.5 mg)

This pill with imprint "WATSON 836 7.5" is Beige, Five-sided and has been identified as Clorazepate dipotassium 7.5 mg. It is manufactured by Watson Laboratories, Inc..

Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 7.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Clorazepate dipotassium 7.5 mg WATSON 836 7.5 Front
Clorazepate dipotassium 7.5 mg WATSON 836 7.5 Back
Clorazepate dipotassium 7.5 mg WATSON 836 7.5
Discount Card Promo
Clorazepate dipotassium
WATSON 836 7.5
7.5 mg
Prescription only
Drug Class:
Pregnancy Category:
N - Not classified
CSA Schedule:
4 - Some potential for abuse
Watson Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.